6个月的结果,一个超门跨导管中枢替换:一个早期的可行性研究
Philippe Généreux1, Krzysztof Wróbel2, Vlasis Ninios3
1Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA. Electronic address: https://twitter.com/PhilGenereuxMD.
JACC. Cardiovascular interventions
|November 12, 2025
概括
阿尔塔瓦尔夫透气管 mitra 置换 (TMVR) 系统在严重的 mitra 吐 (MR) 不适合手术的患者中表现出高的手术成功和安全性,显示出患者结局的显著改善.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 阿尔塔系统提供了一种新的心房固定方法,用于跨导管 mitra 置换 (TMVR).
- 它的目的是解决现有的跨导管美肌修复和更换装置的局限性.
研究的目的:
- 评估AltaValveTMVR系统的程序可行性,安全性和性能.
- 该研究的重点是患有有症状的额头肌吐 (MR) 的患者,这些患者不是手术的候选人.
主要方法:
- 阿尔塔早期可行性研究招募了30名患者.
- 技术成功是主要终点,由手术死亡率,成功的植入物输送/取回以及没有紧急重新干预来定义.
- 心声图数据和临床事件被独立评估.
主要成果:
- 实现了96.7%的高技术成功率.
- 所有幸存的患者在30天后都有轻度或较小的MR,在大多数情况下在6个月后保持.
- 在6个月内没有中风,新的起器植入或重新干预发生;功能类和生活质量得到改善.
结论:
- 阿尔塔 TMVR 系统可行且安全用于治疗高风险患者的显著MR.
- 该设备在6个月的随访中显示出良好的门功能和积极的临床结果.
相关概念视频
Mitral Stenosis III: Medical Management
229
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
229
Mitral Valve Prolapse II: Assessment and Management
397
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
397
Mitral Stenosis I: Introduction
423
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
423
Mitral Stenosis II: Clinical features and Diagnostic Tests
206
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
206
Mitral Valve Prolapse I: Introduction
359
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
359
Mitral Regurgitation III: Medical Management
261
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
261


